| Name | Dectrekumab |
|---|
| Description | Dectrekumab (QAX576) is a humanized monoclonal antibody that targets IL-13. Dectrekumab significantly improves intraepithelial esophageal eosinophil counts and dysregulated esophageal disease-related transcripts with Eosinophilic esophagitis (EoE) in a sustained manner and can be used for inflammation and immunology related research[1]. |
|---|---|
| Related Catalog | |
| Target |
IL-13 |
| References |
| No Any Chemical & Physical Properties |